| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/01/2007 | US20070048257 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/01/2007 | US20070048256 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 03/01/2007 | US20070048223 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048222 Cytokine receptor zcytor17 multimers |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048219 drug/polymer and biological conjugates/, used as angiogenesis inhibitors, for diagnosis and therapy of vision disorders |
| 03/01/2007 | US20070048218 Compositions and Methods for the Diagnosis and Treatment of Tumor |
| 03/01/2007 | CA2794554A1 Process for preparing antibody maytansinoid conjugates |
| 03/01/2007 | CA2620306A1 Devices, compositions and methods for the protection and repair of cells and tissues |
| 03/01/2007 | CA2619491A1 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 03/01/2007 | CA2619052A1 Anti-il-23 antibiodies |
| 03/01/2007 | CA2587766A1 Engineering fc antibody regions to confer effector function |
| 02/28/2007 | EP1757941A1 Method for immunochemically assaying anti-hm1.24 antibody |
| 02/28/2007 | EP1757937A2 Antagonists of HMG1 for treating inflammatory conditions |
| 02/28/2007 | EP1757934A1 Method for screening compounds against flaviviruses by using persistent virus-infected cell system |
| 02/28/2007 | EP1757701A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757699A1 cDNAs encoding secreted proteins |
| 02/28/2007 | EP1757698A1 Polypeptides having dna polymerase activity |
| 02/28/2007 | EP1757697A2 Group B streptococcus antigens |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA |
| 02/28/2007 | EP1757691A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103 |
| 02/28/2007 | EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product |
| 02/28/2007 | EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/28/2007 | EP1757686A1 Cell death inducer |
| 02/28/2007 | EP1757622A1 Bivalent IgY antibody constructs for diagnostic and therapeutic applications |
| 02/28/2007 | EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders |
| 02/28/2007 | EP1757620A2 Cancerous disease modifying antibodies |
| 02/28/2007 | EP1757618A2 Angiogenesis-associated proteins, and nucleic acids encoding the same |
| 02/28/2007 | EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth |
| 02/28/2007 | EP1757616A2 Semaphorin receptors |
| 02/28/2007 | EP1757615A1 Fusion protein for inhibiting cervical cancer |
| 02/28/2007 | EP1757311A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 02/28/2007 | EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 02/28/2007 | EP1756584A2 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals |
| 02/28/2007 | EP1756577A2 Methods and compositions for the detection of cervical disease |
| 02/28/2007 | EP1756571A2 Real time method of detecting acute inflammatory conditions |
| 02/28/2007 | EP1756570A2 Immunoassays for buprenorphine and norbuprenorphine |
| 02/28/2007 | EP1756281A2 Method for the preparation of optically active epoxides and vicinal diols from styrene epoxides using enantioselective epoxide hydrolases derived from yeasts |
| 02/28/2007 | EP1756166A1 Prostate cancer diagnosis and treatment |
| 02/28/2007 | EP1756165A2 Tissue-specific imaging and therapeutical agents targeting proteins expressed on lung endothelial cell surface |
| 02/28/2007 | EP1756164A2 Dr5 antibodies and uses thereof |
| 02/28/2007 | EP1756163A2 Method of treating granuloma annulare or sarcoid |
| 02/28/2007 | EP1756162A1 Receptor coupling agents and therapeutic uses thereof |
| 02/28/2007 | EP1756161A2 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and of complexes comprising them |
| 02/28/2007 | EP1756151A1 Osteoblast growth factor |
| 02/28/2007 | EP1756144A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof |
| 02/28/2007 | EP1755675A2 Il-13 binding agents |
| 02/28/2007 | EP1755674A2 Prolongation of survival of an allograft by inhibiting complement activity |
| 02/28/2007 | EP1755673A2 Anti-il-9 antibody formulations and uses thereof |
| 02/28/2007 | EP1755670A2 Methods for treating vascular disease |
| 02/28/2007 | EP1755669A2 Methods and compositions for specifically targeting human hepatocellular carcinoma cells |
| 02/28/2007 | EP1755660A2 Method for enhancing or inhibiting insulin-like growth factor-i |
| 02/28/2007 | EP1755659A2 Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation |
| 02/28/2007 | EP1755646A2 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 02/28/2007 | EP1755645A2 Vegf inhibitors for the treatment of malignant pleural effusion |
| 02/28/2007 | EP1755641A2 Agonists and antagonists of p28, ebi3 and wsx/tccr for treating immune disorders |
| 02/28/2007 | EP1755626A1 USES OF BISPECIFIC ANTIBODY (Biab) COATED DENDRITIC CELLS PULSED WITH ANTIGENS |
| 02/28/2007 | EP1664085A4 Detecting molecules |
| 02/28/2007 | EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 02/28/2007 | EP1346041B1 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 02/28/2007 | EP1248848B1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides |
| 02/28/2007 | EP1189634B1 Treating prostate cancer with anti-erbb2 antibodies |
| 02/28/2007 | EP1077999B1 Moraxella catharralis proteins |
| 02/28/2007 | EP1073737B1 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/28/2007 | EP0945506B1 Proteine avec une activite de suppression du vieillissement |
| 02/28/2007 | EP0938497B1 Constrained helical peptides and methods of making same |
| 02/28/2007 | EP0909323B1 Helicobacter pylori bacterioferritin |
| 02/28/2007 | EP0888122B1 HYBRID WITH INTERFERON-alpha AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 02/28/2007 | EP0833840B1 Hypoxia inducible factor-1 and method of use |
| 02/28/2007 | EP0770628B9 Reconstituted human antibody against human interleukin-8 |
| 02/28/2007 | EP0758390B1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/28/2007 | CN1922324A Bacterial virulence factors and uses thereof |
| 02/28/2007 | CN1922316A Mutants of anti-cd40 antibody |
| 02/28/2007 | CN1922210A Monovalent antibody fragments useful as therapeutics |
| 02/28/2007 | CN1922209A Anti-ab antibody |
| 02/28/2007 | CN1922208A Methods and compositions for inhibiting c-met dimerization and activation |
| 02/28/2007 | CN1922207A A method of providing a purified, virus safe antibody preparation |
| 02/28/2007 | CN1922202A Lsa-5 liver stage and blood stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 02/28/2007 | CN1922199A Ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921878A Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 02/28/2007 | CN1920027A Human hPTP gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920026A Human hMnk2 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920025A Human hNP25 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920024A Human hARPP-21 gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920023A Human heIF2a gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920022A Human hMKPx gene order, encode albumen and preparation method thereof |
| 02/28/2007 | CN1920014A Phosphokinase PKD2 and application thereof |
| 02/28/2007 | CN1920013A Nevoid basal cell carcinoma syndrome pathogenic gene and encode albumen thereof |
| 02/28/2007 | CN1920011A Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells |
| 02/28/2007 | CN1919871A B7. 1-CD19scFv fusion gene engineering albumen for treating B lymphocyte leukemia and lymph tumour and use thereof |
| 02/28/2007 | CN1919869A CYP3A4 polypeptide and preparation method of polypeptide antibody to human CYP3A4 |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/27/2007 | US7183402 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/27/2007 | US7183401 Tumor suppressor protein (designated NOEY2) expressed in normal ovarian and breast surface epithelial cells but absent or down-regulated in ovarian and breast cancer cells; vectors, host cells, detection kits |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |